ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Gilead pushes on with NASH drug after phase 2 success
pharmaphorum
December 06, 2018Gilead Sciences presented promising data on its research into advanced fibrosis caused by non-alcoholic steatohepatitis (NASH), one of several big pharma companies developing drugs for the currently untreatable disease.
Pharma Sources Insight July 2025
